Parlodel
Indicated to support motor function in Parkinson's disease, utilized to alleviate symptoms by mimicking natural dopamine activity within the central nervous system.
- Category
- Neurology
- Active ingredient
- Bromocriptine
- Supply
- Pharmacy
- Route
- Oral use
- Form
- Tablet
- Strengths
- 2.5mg
Parlodel details
- Conditions
- Parkinson's Disease · Hyperprolactinaemia · Acromegaly
- Therapeutic class
- Dopamine Agonist
- Pharmacological class
- Ergot derivative
- Minor side effects
- nausea; dizziness; fatigue
- Moderate side effects
- hypotension; hallucinations; confusion
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Pharmacist only, dispensed without a prescription
- Manufacturer
- Novartis
- Onset Time
- 2–4 weeks
- Duration
- 6–8 hours
- Storage instructions
- Store below 25°C, away from light.
- Drug interactions
- Antipsychotics; erythromycin; blood pressure medications
- Age restrictions
- Use with caution in elderly patients.
- Pregnancy and breastfeeding
- Avoid during pregnancy unless clearly indicated; stops lactation.
Contraindications
uncontrolled hypertension; severe coronary artery disease; history of psychosis; hypersensitivity to ergot alkaloids
Precautions and warnings
monitor blood pressure; avoid rapid changes in posture to prevent dizziness; use caution if history of cardiac arrhythmia
Serious side effects
myocardial infarction, requires immediate medical attention; stroke, requires immediate medical attention; seizures, requires immediate medical attention
Patient summary
Indicated to support motor function in Parkinson's disease, utilized to alleviate symptoms by mimicking natural dopamine activity within the central nervous system.
Mechanism of action
Bromocriptine is a dopamine receptor agonist that stimulates dopamine D2 receptors in the brain. This activity helps regulate hormone production and compensate for the loss of natural dopamine in patients with Parkinson's disease.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Parlodel
Parlodel is a dopamine agonist containing the active ingredient Bromocriptine, utilized for the clinical management of Parkinson’s Disease, Hyperprolactinaemia and Acromegaly. Manufactured by Novartis, the medication is supplied as a 2.5mg tablet. The formulation allows for the steady, titrated management often required by patients dealing with these complex hormonal and neurological conditions.
Buying Parlodel online
Parlodel is registered across 14 markets including Thailand, Malaysia and the Philippines, with further availability in countries such as Indonesia, Taiwan and South Korea. One of the most ordered medications for these conditions across the region, it helps expats and local residents secure a reliable supply. While generic Bromocriptine, often produced in India, provides a more budget-friendly alternative to the original Novartis brand, Parlodel remains a preferred choice for those seeking the established standards of a major manufacturer.